| MAC (N = 40) | RIC (N = 40) | |||
|---|---|---|---|---|
| Outcomes | N (at risk) | Prob (90% Cl) | N (at risk) | Prob (90% Cl) |
| Overall survival | 11 | 62.4 (49.5-74.5)% | 11 | 69.6 (55.8-81.8)% |
| Non-relapse mortality | 9 | 10 (3.5-19.2)% | 9 | 14.7 (5.7-26.9)% |
| Relapse | 9 | 50.5 (36.3-64.7)% | 9 | 29.4 (17.7-42.7)% |
| Progression-free survival | 8 | 39.5 (26.4-53.4)% | 8 | 55.9 (41.6-69.8)% |
| cGVHD | 6 | 37.5 (25.2-50.6)% | 6 | 20 (10.6-31.5)% |
| Severe cGVHD | 8 | 12.5 (5.2-22.4)% | 12 | 5 (0.9-12.2)% |
| GRFS | 3 | 16.9 (8.2-27.8)% | 5 | 44.3 (30.6-58.5)% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.